The Management of Infection and Colonization due to Methicillin‐Resistant Staphylococcus aureus: A CIDS/CAMM Position Paper
Authors:
- Andrew E SimorASAndrew E Simor
- Mark LoebMLMark Loeb
- the CIDS/CAMM Guidelines Committee,TCthe CIDS/CAMM Guidelines Committee,
Open Access
- 1 January 2004
- journal article
- research article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 15 (1) , 39-48
Abstract
Methicillin‐resistant Staphylococcus aureus (MRSA) is being seen with greater frequency in most hospitals and other health care facilities across Canada. The organism may cause life‐threatening infections and has been associated with institutional outbreaks. Several studies have confirmed that MRSA infection is associated with increased morbidity and mortality compared with infections caused by susceptible strains, even when the presence of comorbidities is accounted for. Treatment of MRSA infection is complicated by the fact that these organisms are resistant to multiple antimicrobial agents, so treatment options are limited. The effectiveness of decolonization therapy (attempting to eradicate MRSA carriage) is also uncertain. This paper reviews the medical management of MRSA infections, discusses the potential role of decolonization and provides an overview of evidence to support recommended infection control practices.Keywords
This publication has 128 references indexed in Scilit:
- GemifloxacinDrugs, 2000
- Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycinJournal of Antimicrobial Chemotherapy, 1999
- Quinupristin/DalfopristinDrugs, 1999
- Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesJournal of Antimicrobial Chemotherapy, 1995
- A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patientsJournal of Antimicrobial Chemotherapy, 1994
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centresJournal of Antimicrobial Chemotherapy, 1991
- Treatment of Prosthetic Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus with MinocyclineThe Journal of Infectious Diseases, 1990
- Comparison of the Invesligalional drug, LV146032, with vancomycin in experimental pneumonia due to methidillln-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1988
- Control and Eradication of Methicillin-ResistantStaphylococcus aureuson a Surgical UnitNew England Journal of Medicine, 1984